Stockreport

IceCure Medical Reports Positive Topline Results From ICE3 Cryoablation Breast Cancer Study: Achievement of 96.39% Recurrence Free Rate Brings Company One Step Closer to Providing Women a ...

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF Study represents largest cryoablation study of its kind in the U.S. for early-stage low-risk malignant breast tumors CAESAREA, Israel March 19, 2024 /PRNewswire/ -- I [Read more]